288,670 Shares in Envista Holdings Corporation $NVST Acquired by Ieq Capital LLC

Ieq Capital LLC acquired a new stake in shares of Envista Holdings Corporation (NYSE:NVST) during the 2nd quarter, HoldingsChannel.com reports. The fund acquired 288,670 shares of the company’s stock, valued at approximately $7,606,000.

Other institutional investors have also recently added to or reduced their stakes in the company. GSA Capital Partners LLP acquired a new stake in shares of Envista in the 2nd quarter valued at $2,039,000. Dimensional Fund Advisors LP boosted its holdings in Envista by 1.6% in the first quarter. Dimensional Fund Advisors LP now owns 9,780,948 shares of the company’s stock worth $248,130,000 after purchasing an additional 152,488 shares in the last quarter. Pzena Investment Management LLC acquired a new position in Envista during the second quarter worth $30,494,000. SummitTX Capital L.P. acquired a new position in Envista during the first quarter worth $4,268,000. Finally, Principal Financial Group Inc. raised its holdings in Envista by 36.8% during the first quarter. Principal Financial Group Inc. now owns 483,983 shares of the company’s stock valued at $12,279,000 after buying an additional 130,237 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. JPMorgan Chase & Co. boosted their price target on Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Zacks Research raised Envista from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. Mizuho set a $29.00 price objective on Envista in a research note on Thursday, August 6th. Evercore restated an “outperform” rating and issued a $33.00 target price on shares of Envista in a report on Thursday, May 7th. Finally, Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a research report on Saturday. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $29.31.

Envista Price Performance

Shares of NVST stock opened at $27.21 on Monday. Envista Holdings Corporation has a 12 month low of $18.77 and a 12 month high of $30.42. The company has a market capitalization of $4.37 billion, a P/E ratio of 46.91, a P/E/G ratio of 1.30 and a beta of 0.86. The stock has a 50 day moving average of $26.90 and a two-hundred day moving average of $26.30. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.34 by $0.07. The business had revenue of $730.50 million for the quarter, compared to analysts’ expectations of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.Envista’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.26 earnings per share. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, equities analysts expect that Envista Holdings Corporation will post 1.53 EPS for the current year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.